
Ozempic muscle-loss risk prompts medical guidance for mitigation
Health experts warn that GLP-1 weight-loss drugs like Ozempic can cause substantial lean-mass loss in a sizable portion of users, potentially accelerating sarcopenia and increasing fall risk, especially among older adults; however, doctors advise mitigating strategies such as high-protein diets, regular strength training, and close medical follow-up to preserve muscle while maintaining weight-loss benefits.












